Synthesis of novel cyclic protease inhibitors using Grubbs olefin metathesis

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 4, 1998, Pages 357-360

  Ripka, Amy S ^a   Bohacek, Regine S ^b   Rich, Daniel H ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b ARIAD PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKENE; AMINO ACID; ASPARTIC PROTEINASE; BISHOMOALLYLGLYCINE; ENZYME INHIBITOR; PEPSIN A; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYCLIZATION; DRUG SYNTHESIS; NONHUMAN; RHIZOPUS;

EID: 0032539507     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00025-0     Document Type: Article

References (23)

1. 1. Wiley, R. A.; Rich, D. H. Medicinal Research Reviews, Vol 13, No. 3, John Wiley & Sons Inc., New York, 1993; pp 327.
2. 2. Hart, P. A.; Rich, D. H. In The Practice of Medicinal Chemistry; Wermuth, C. Ed.; Academic Press: New York, 1996; pp 393.
3. 3. Freidinger, R. M.; Veber, D. F. In Conformationally Directed Drug Design; Visa, J.A., Gordon, M., Eds.; American Chemical Society: Washington, D.C., 1984; pp 169.
4. 4. Fairlie, D. P.; Abbenante, G.; March, D. R. Curr. Med. Chem. 1995, 2, 654.
5. 5. Schechter, I.; Berger, A. Biochem. Biophys. Res. Commun. 1967, 27, 157.
6. 6. Janetka, J. W.; Rich, D. H. J. Am. Chem. Soc., 1997, 119, 6488.
7. 7. Janetka, J. W.; Raman, P.; Satyshur, K.; Flentke, G. R.; Rich, D. H. J. Am. Chem. Soc., 1997, 119, 441.
8. 8. Szewczuk, Z.; Rebholz, K. L.; Rich, D. H. Int. J. Peptide Protein Res. 1992, 40, 233.
9. 9. Podlagar, B. L.; Farr, R. A.; Friedlich, D.; Tarnus, C.; Huber, E. W.; Cregge, R. J.; Schirlin, D. J. Med. Chem. 1994, 37, 3684.
10. 10. Reid, R. C.; March, D. R.; Dooley, M. J.; Bergman, D. A.; Abbenante, G.; Fairlie, D. P. J. Am. Chem. Soc. 1996, 118, 8511.
11. 11. Bohacek, R. S.; McMartin, C. J. Am. Chem. Soc. 1994, 116, 5560.
12. 12. Rich, D. H.; Bohacek, R. S.; Dales, N. A.; Glunz, P.; Ripka, A. S. Chimia 1997, 51, 45-47.
13. 13. a) Suguna, K.; Bott, R. R.; Padlan, E. A.; Subramanian, E.; Sheriff, S.; Cohen, G. H.; Davies, D. R. J. Mol. Biol. 1987, 196, 877.
14. b) Bott, R. R.; Davies, D. R. In Proceedings of the Eighth American Peptide Symposium, Hruby, V. J., Rich, D. H., Eds.; Pierce Chemical Co.: Rockford, 1983; pp 531.
15. 14. Evans, D. A.; Weber, A. E. J. Am. Chem. Soc. 1986, 108, 6757. Evans, D. A.; Britton, T. C.; Ellman, J. A.; Dorow, R. L. J. Am. Chem. Soc. 1990, 112, 4011.
16. 14. Evans, D. A.; Weber, A. E. J. Am. Chem. Soc. 1986, 108, 6757. Evans, D. A.; Britton, T. C.; Ellman, J. A.; Dorow, R. L. J. Am. Chem. Soc. 1990, 112, 4011.
17. 15. Acid 12 was shown to be ≥98% enantiomerically pure by conversion to the (R)-methylbenzyl amide and subsequent NMR analysis of the diastereomer.
18. 16. Schwab, P.; Grubbs, R. H.; Ziller, J. W. J. Am. Chem. Soc. 1996, 118, 100-110.
19. 17. The E/Z ratio of the diastereomers is approximately 1:1.
20. 13C NMR, and thin layer chromatography.
21. 19. Peranteau, A. G.; Kuzmic, P.; Angell, Y.; Garcia-Escheverria, C.; Rich, D. H. Anal. Biochem. 1995, 227, 242.
22. 20. Miller, S. J.; Grubbs, R. H. J. Am. Chem. Soc. 1995, 177, 5855.
23. 21. Miller, S. J.; Blackwell, H. E.; Grubbs, R. H. J. Am. Chem. Soc. 1996, 118, 9606.